Skip to content

Comparison of the efficacy of 5% glucose solution and saline solution in shoulder joint hydraulic distension for the treatment of frozen shoulder

Comparison of the efficacy of 5% glucose solution and saline solution in shoulder joint hydraulic distension for the treatment of frozen shoulder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096015
Enrollment
Unknown
Registered
2025-01-16
Start date
2025-01-20
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

frozen shoulder

Interventions

5% glucose group:Under ultrasound guidance, an injection of 1 ml of compound betamethasone + 4 ml of 2% lidocaine + 15 ml of 5% glucose into the shoulder joint.
saline group:Under ultrasound guidance, an injection of 1 ml of compound betamethasone + 4 ml of 2% lidocaine + 15 ml of 5% glucose into the shoulder joint.

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria were: 1) Aged 40 years or older; 2) Symptoms of unilateral shoulder stiffness with pain for at least 1 month; 3) Passive ROM in at least two planes restricted by more than 30 degree compared to the contralateral or normal side; 4) MRI findings consistent with FS changes (e.g., thickening of the rotator cuff interval, coracohumeral ligament, and joint capsule, complete occlusion of the subacromial fat triangle).

Exclusion criteria

Exclusion criteria: Exclusion criteria were 1) Bilateral FS; 2) Shoulder joint trauma or fracture; 3) History of shoulder joint surgery; 4) Receiving any other treatment within the past 4 weeks (except for oral medications); 5) Received shoulder joint injections in the past 3 months; 6) Systemic inflammatory diseases (e.g., rheumatoid arthritis or osteoarthritis); 7) Pregnancy, infections, mental disorders, severe cardiovascular and cerebrovascular diseases, or liver and renal failure; 8) Allergies to any of the medications used in the study; 9) Coagulation disorders.

Design outcomes

Primary

MeasureTime frame
Scoring of shoulder pain and disability index;

Secondary

MeasureTime frame
The numerical value of the digital rating scale;Numerical value of active range of motion of shoulder joint;

Countries

China

Contacts

Public ContactYin Qin

Department of pain, Affiliated Hospital of Xuzhou Medical University

1915992218@qq.com+86 177 1826 0192

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026